Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MEN 16132

Known as: MEN-16132, MEN16132 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
In osteoarthritis (OA), bradykinin (BK) is known to contribute to pain and synovitis, but not to cartilage degradation. Here, we… Expand
2010
2010
Dry and persistent cough is one of the commonest side effects experienced by patients treated with angiotensin-converting enzyme… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
2010
2010
BACKGROUND AND PURPOSE Bradykinin, through its B2 receptor, is involved in inflammatory processes related to arthropathies. In… Expand
2010
2010
Inhaled bradykinin causes bronchoconstriction in asthmatic subjects but not nonasthmatics. To date, animal studies with inhaled… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
Background and purpose:  Bradykinin (BK) and B2 receptors have been implicated in the pathophysiology of osteoarthritis (OA), and… Expand
2009
2009
The present study was designed to investigate the role of bradykinin (BK) in the knee joint osteoarthritis induced by intra… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
The pharmacological profile of the bradykinin B(2) receptor antagonist MEN16132 at the rat B(2) receptor has been investigated… Expand
2007
2007
The aim was to characterize the recently discovered non‐peptide antagonist MEN16132 at the mouse B2 receptor, relative to other… Expand
2005
2005
The pharmacological characterization of the novel nonpeptide antagonist for the B2 receptor, namely MEN16132 (4-(S)-Amino-5-(4-{4… Expand
2005
2005
We have tested the activity of 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6